Recent experiments suggest that drugs that bind to the peroxisome proliferation-activated receptor gamma (PPARγ agonist medications) may be neuroprotective (prevent nerve cell loss) in animal models of PD. This evidence concerns the gene PPARG and Parkinson disease.